Kosdaq listed drug companies achieved 30% sales growth in first half of this year.

9 pharmaceutical companies listed in the Kosdaq had achieved over 30% net sales growth, 70% and 55% of the ordinary and net profits respectively during the first half of this year, showing overall excellent business performances.

Kyungdong recorded 24.3 BW of net sales, 31% growth, 46% and 38.5% ordinary and net profits respectively over the previous year period.

Samchulli sold 20.6 BW of...